Ultrasound Targeted Molecular Imaging in Large Arteries to Diagnose Stroke Risk

大动脉超声靶向分子成像诊断中风风险

基本信息

  • 批准号:
    8528708
  • 负责人:
  • 金额:
    $ 34.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-15 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Approximately 1.1 million deaths each year are a result of emboli from carotid artery atherosclerosis. These deaths are highly preventable through lifestyle changes or drug therapy if the development of atherosclerosis is detected prior to plaque formation. Similarly, interventional treatment and therapy is available with good clinica efficacy at later stages of the disease if carotid plaques can be adequately characterized (i.e. vulnerable versus stable plaques). Ultrasound-based targeted molecular imaging represents an emerging technology with potential to provide both earlier detection of carotid atherosclerosis and more specific diagnosis and characterization of carotid plaques. However, current use of microbubble-based ultrasound imaging in the clinic is limited to a narrow set of indications (e.g. liver nodule diagnosis) and current clinical use of targeted microbubble imaging is non-existent largely due to technical challenges associated with imaging in large arteries. The overarching goal of this project is to break down the technological barriers currently preventing clinical utilty of ultrasound-based targeted molecular imaging for prevention of stroke. Successful achievement of this goal will involve in vivo demonstration of a novel targeted molecular imaging technology, called singular spectrum-based targeted molecular (SiSTM) imaging, with greater than 95% sensitivity and specificity for detection of early molecular markers for atherosclerosis in rabbit aorta arteries. Beam sequences specific to SiSTM imaging will be optimized for enhanced sensitivity and specificity including an adaptive blood velocity correction technique. Additionally, a dual frequency 1.5D molecular imaging probe will be designed, fabricated, and implemented on a research scanner. In vivo sensitivity and specificity of SiSTM imaging in large arteries will be assessed using Watanabe heritable hyperlipidemic strain (WHHL) rabbits exhibiting genetic predisposition for extreme hypercholesterolemia and advanced atherosclerosis. Immunohistochemistry results for disease markers will be correlated with SiSTM imaging data.
描述(由申请人提供):每年约有110万人死于颈动脉粥样硬化栓塞。如果在斑块形成之前检测到动脉粥样硬化的发展,这些死亡是高度可预防的,通过改变生活方式或药物治疗。同样,如果颈动脉斑块能够充分表征(即易损斑块与稳定斑块),则介入治疗和疗法在疾病的后期阶段具有良好的临床疗效。基于超声的靶向分子成像代表了一种新兴技术,具有提供颈动脉粥样硬化的早期检测和颈动脉斑块的更特异性诊断和表征的潜力。然而,基于微泡的超声成像在临床中的当前使用仅限于一组狭窄的适应症(例如,肝结节诊断),并且靶向微泡成像的当前临床使用在很大程度上由于与大动脉中的成像相关的技术挑战而不存在。该项目的总体目标是打破目前阻碍基于超声的靶向分子成像用于预防中风的临床实用性的技术障碍。这一目标的成功实现将涉及一种新的靶向分子成像技术的体内演示,称为基于奇异谱的靶向分子(SiSTM)成像,具有超过95%的灵敏度和特异性检测兔主动脉粥样硬化的早期分子标志物。针对SiSTM成像的射束序列将进行优化,以增强灵敏度和特异性,包括自适应血流速度校正技术。此外,双频1.5D分子成像探针将被设计,制造,并在研究扫描仪上实现。将使用表现出极端高胆固醇血症和晚期动脉粥样硬化的遗传倾向的Watanabe遗传性高胆固醇血症品系(WHHL)兔评估大动脉中SSTM成像的体内灵敏度和特异性。疾病标志物的免疫组织化学结果将与SiSTM成像数据相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John A Hossack其他文献

John A Hossack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John A Hossack', 18)}}的其他基金

Accelerated Low Dose Thrombolytic Catheter Directed Sonothrombolysis
加速低剂量溶栓导管定向声溶栓
  • 批准号:
    10192806
  • 财政年份:
    2018
  • 资助金额:
    $ 34.26万
  • 项目类别:
Ultrasound Targeted Molecular Imaging in Large Arteries to Predict AAA Risk
大动脉超声靶向分子成像可预测 AAA 风险
  • 批准号:
    9194510
  • 财政年份:
    2016
  • 资助金额:
    $ 34.26万
  • 项目类别:
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.
定制超声技术探索脾神经免疫轴激活减轻急性器官损伤的机制。
  • 批准号:
    9341636
  • 财政年份:
    2016
  • 资助金额:
    $ 34.26万
  • 项目类别:
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.
定制超声技术探索脾神经免疫轴激活减轻急性器官损伤的机制。
  • 批准号:
    9150562
  • 财政年份:
    2015
  • 资助金额:
    $ 34.26万
  • 项目类别:
Tailoring ultrasound technology to explore mechanisms of activation of the splenic neuroimmune axis in attenuating acute organ injury.
定制超声技术探索脾神经免疫轴激活减轻急性器官损伤的机制。
  • 批准号:
    9054531
  • 财政年份:
    2015
  • 资助金额:
    $ 34.26万
  • 项目类别:
Ultrasound Targeted Molecular Imaging in Large Arteries to Diagnose Stroke Risk
大动脉超声靶向分子成像诊断中风风险
  • 批准号:
    8371330
  • 财政年份:
    2012
  • 资助金额:
    $ 34.26万
  • 项目类别:
Ultrasound Targeted Molecular Imaging in Large Arteries to Diagnose Stroke Risk
大动脉超声靶向分子成像诊断中风风险
  • 批准号:
    8675928
  • 财政年份:
    2012
  • 资助金额:
    $ 34.26万
  • 项目类别:
PiV Ultra 12 - 24 Ultra High Speed Camera for Ultrasound Microbubble Research
PiV Ultra 12 - 24 用于超声微泡研究的超高速相机
  • 批准号:
    7595606
  • 财政年份:
    2009
  • 资助金额:
    $ 34.26万
  • 项目类别:
VisualSonics Vevo 2100 Small Animal Ultrasound Imaging System and Accessories
VisualSonics Vevo 2100 小动物超声成像系统和配件
  • 批准号:
    7792714
  • 财政年份:
    2009
  • 资助金额:
    $ 34.26万
  • 项目类别:
Molecular Targeted, Focused, Ultrasound-Based Delivery of Antiproliferative Drugs
抗增殖药物的分子靶向、聚焦、超声递送
  • 批准号:
    8296580
  • 财政年份:
    2008
  • 资助金额:
    $ 34.26万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.26万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.26万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.26万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 34.26万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 34.26万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 34.26万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 34.26万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 34.26万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 34.26万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 34.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了